Yu Fan Purchases New Shares in Kestra Medical Technologies, Ltd. $KMTS

Key Points

• Yu Fan invested approximately $56.88 million in Kestra Medical Technologies by purchasing 2,282,519 shares, making it his largest position, accounting for 58.1% of his holdings.
• Several institutional investors, including Brown Advisory Inc. and Federated Hermes Inc., also acquired new stakes in Kestra during the first quarter, reflecting growing interest in the company.
• Analysts have adjusted their target price for Kestra Medical Technologies, with Wells Fargo lowering it from $28.00 to $27.00, while maintaining an "overweight" rating, indicating a generally positive outlook on the stock.

Yu Fan purchased a new stake in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,282,519 shares of the company's stock, valued at approximately $56,880,000. Kestra Medical Technologies makes up about 58.1% of Yu Fan's holdings, making the stock its biggest position. Yu Fan owned about 4.45% of Kestra Medical Technologies at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of KMTS. Brown Advisory Inc. bought a new position in Kestra Medical Technologies in the first quarter valued at approximately $13,716,000. Caas Capital Management LP bought a new stake in shares of Kestra Medical Technologies in the first quarter worth $1,470,000. Jennison Associates LLC bought a new stake in shares of Kestra Medical Technologies in the first quarter worth $1,869,000. TD Asset Management Inc bought a new stake in shares of Kestra Medical Technologies in the first quarter worth $2,306,000. Finally, Federated Hermes Inc. bought a new stake in shares of Kestra Medical Technologies in the first quarter worth $9,968,000.

Kestra Medical Technologies Price Performance

Shares of NASDAQ:KMTS traded up $3.43 on Friday, hitting $21.83. The company had a trading volume of 807,875 shares, compared to its average volume of 227,238. Kestra Medical Technologies, Ltd. has a 1-year low of $13.25 and a 1-year high of $26.15. The stock's 50 day moving average is $16.45. The company has a debt-to-equity ratio of 0.20, a current ratio of 6.72 and a quick ratio of 6.72.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company cut their price objective on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating on the stock in a research report on Thursday, July 17th. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, Kestra Medical Technologies presently has a consensus rating of "Moderate Buy" and a consensus target price of $27.33.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.